| Literature DB >> 26007332 |
Matthew P G Barnett1,2,3, Emma N Bermingham4,5, Wayne Young6,7, Shalome A Bassett8,9, John E Hesketh10, Anabel Maciel-Dominguez11, Warren C McNabb12,13, Nicole C Roy14,15,16,17.
Abstract
During pregnancy, selenium (Se) and folate requirements increase, with deficiencies linked to neural tube defects (folate) and DNA oxidation (Se). This study investigated the effect of a high-fat diet either supplemented with (diet H), or marginally deficient in (diet L), Se and folate. Pregnant female mice and their male offspring were assigned to one of four treatments: diet H during gestation, lactation and post-weaning; diet L during gestation, lactation and post-weaning; diet H during gestation and lactation but diet L fed to offspring post-weaning; or diet L during gestation and lactation followed by diet H fed to offspring post-weaning. Microarray and pathway analyses were performed using RNA from colon and liver of 12-week-old male offspring. Gene set enrichment analysis of liver gene expression showed that diet L affected several pathways including regulation of translation (protein biosynthesis), methyl group metabolism, and fatty acid metabolism; this effect was stronger when the diet was fed to mothers, rather than to offspring. No significant differences in individual gene expression were observed in colon but there were significant differences in cell cycle control pathways. In conclusion, a maternal low Se/folate diet during gestation and lactation has more effects on gene expression in offspring than the same diet fed to offspring post-weaning; low Se and folate in utero and during lactation thus has persistent metabolic effects in the offspring.Entities:
Keywords: folate; high-fat diet; microarray analysis; selenium
Mesh:
Substances:
Year: 2015 PMID: 26007332 PMCID: PMC4446756 DOI: 10.3390/nu7053370
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Composition of experimental diets (as formulated).
| Macronutrient | Diet “L” (0.4 mg Folate + 0.08 mg Se/kg) | Diet “H” (2.4 mg Folate+ 0.44 mg Se/kg) | |||
|---|---|---|---|---|---|
| gm % | kcal% | gm % | kcal% | ||
| Protein | 20 | 17 | 20 | 17 | |
| Carbohydrate | 49 | 42 | 50 | 43 | |
| Fat | 21 | 40 | 21 | 40 | |
| Total | 99 | 100 | |||
| kcal/g | 4.68 | 4.68 | |||
|
|
|
|
|
| |
| Casein | 195 | 780 | 195 | 780 | |
| 3 | 12 | 3 | 12 | ||
| Corn Starch | 50 | 200 | 50 | 200 | |
| Matodextrin 10 | 100 | 400 | 100 | 400 | |
| Sucrose | 341 | 1364 | 341 | 1364 | |
| Cellulose BW200 | 50 | 0 | 50 | 0 | |
| Milk Fat Anhydrous | 200 | 1800 | 200 | 1800 | |
| Corn Oil | 10 | 90 | 10 | 90 | |
| Mineral Mix S10001 † | 0 | 35 | |||
| Sodium Selenite (45.7% Se) | 0.000067 | 0.00058 | |||
| Mineral mix S19101 (no Se) | 35 | 0 | |||
| Calcium Carbonate | 4 | 4 | |||
| Vitamin Mix V10001 ‡ | 0 | 10 | 40 | ||
| Vitamin mix V14901 (no Fo) | 10 | 40 | 0 | ||
| Folic Acid | 0.00032 | 0.00032 | |||
| Choline Bitartrate | 2 | 2 | |||
| Cholesterol USP | 1.5 | 1.5 | |||
| Ethoxyquin | 0.04 | 0.04 | |||
| FD&C Yellow Dye #5 | 0.05 | 0 | |||
| FD&C Red Dye #40 | 0 | 0.05 | |||
|
|
|
|
|
| |
† S1001: Calcium Phosphate, Dibasic, 29.5% Ca, 22.8% P 500 gm; Magnesium Oxide, 60.3% Mg 24 gm; Potassium Citrate, 1 H2O, 36.2% K 220 mg; Potassium Sulfate, 44.9% K, 18.4% S 52 gm; Sodium Chloride, 39.3% Na, 60.7% Cl 74 gm; Chromium K Sulfate, 12 H2O, 10.4% Cr 0.55 gm; Cupric Carbonate, 57.5% Cu 0.3 gm; Potassium Iodate, 59.3% I 0.01 gm; Ferric Citrate, 21.2% Fe 6 gm; Manganous Carbonate, 47.8% Mn 3.5 gm; Sodium Selenite, 45.7% Se 0.01 gm (not present in S19101); Zinc Carbonate, 52.1% Zn 1.6 gm; Sucrose 118.03 gm. ‡ V10001: Vitamin A Palmitate, 500,000 IU/gm 0.8 gm; Vitamin D3, 100,000 IU/gm 1 gm; Vitamin E Acetate, 500 IU/gm 10 gm; Menadione Sodium Bisulfite, 62.5% menadione 0.8 gm; Biotin, 1.0% 2 gm; Cyancocobalamin, 0.1% 1 gm; Folic Acid 0.2 gm; Nicotinic Acid 3 gm; Calcium Pantothenate 1.6 gm; Pyridoxine-HCl 0.7 gm; Riboflavin 0.6 gm; Thiamin HCl 0.6 gm; Sucrose 978.42 gm.
Figure 1Partial least squares-discriminant analysis (PLS-DA) of gene expression profiles in colon (left) and liver (right) tissue for genes within the top 5% coefficient of variation; HH (red; n = 6), HL (blue; n = 6), LH (green; n = 6), LL (black; n = 6). Ellipses show 50% confidence interval boundary.
Summary of gene expression changes in liver tissue in response to altered Se/folate levels. Comparisons for which further analyses, including GSEA, were carried out are marked *. For each of the experimental groups, data represent n = 6 animals. DE = differentially expressed.
| Change in Gene Expression | Comparison | ||||
|---|---|---|---|---|---|
| HH
| LH
| HH
| HL
| HH
| |
| Lower expression | 50 | 18 | 13 | 0 | 358 |
| No change | 43,269 | 43,356 | 43,303 | 43,379 | 42,659 |
| Higher expression | 60 | 5 | 63 | 0 | 362 |
| Total DE genes | 110 | 23 | 76 | 0 | 720 |
Figure 2Gene set enrichment analysis (GSEA) of Reactome pathway expression. Size of the circles is proportional to significance (log odds), with increased circle diameter indicating increased significance. Pathways showing difference in expression with significance < 0.01 (i.e., log odds > 2) are coloured red or green depending on the direction of expression shift. Red indicates significantly higher expression in first group, while green indicates higher expression in second group. GSEA of liver comparisons are shown in Tables S3 and S5, differentially expressed genes in the liver are listed in Tables S4 and S6, and GSEA of colon is shown in Table S7. Data represent comparisons between treatments with n = 6 animals in each treatment group.